Released Sep 14, 2011, after the close
10-Q filed Sep 14, 2011, 45 days after period end · 0001354488-11-003435
Q3 2011 · 10-Q
Revenue—
Net Income$1.50M$1.50M +1,134.3% vs Q3 2010+212.4% vs Q2 2011
EPS Diluted$0.07$0.07 +1,240.0% vs Q3 2010+219.0% vs Q2 2011
Gross Profit$1,999,504+125.0%
Operating Income$1,167,579+470.2%
Operating Cash Flow$1,054,280N/M
Free Cash Flowderived$1,051,731N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2011 | Q3 2010 |
|---|---|---|
| Net Income | $1.50M | $121.41K |
| EPS Diluted | $0.07 | $0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pharma-Bio Serv, Inc. · CIK 1304161 · Engraved from SEC EDGAR